Recombinant alpha-fetoprotein C-terminal fragment: The new recombinant vector for targeted delivery

Journal of Drug Targeting

Volumn 16, Issue 4, 2008, Pages 321-328

  Posypanova, Galina A ^a,b   Gorokhovets, Neonila V ^a   Makarov, Vladimir A ^b   Savvateeva, Ludmila V ^b   Kireeva, Natalya N ^c   Severin, Sergey E ^a,b   Severin, Evgeny S ^c  

^a Moscow Research Institute of Medical Ecology   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Russian Research Center of Molecular Diagnostics and Therapy   (Russian Federation)

Author keywords

AFP; AFP receptor; Alpha fetoprotein; Recombinant AFP fragment; Targeted delivery

Indexed keywords

COMPLEMENTARY DNA; CYTOTOXIC AGENT; DNA FRAGMENT; ESTRADIOL; RECEPTOR PROTEIN; RECOMBINANT ALPHA FETOPROTEIN; RECOMBINANT PROTEIN;

ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR CELL;

ALPHA-FETOPROTEINS; ANTINEOPLASTIC AGENTS; BACTERIA; CELL LINE, TUMOR; DNA, COMPLEMENTARY; DRUG CARRIERS; ESCHERICHIA COLI; ESTRADIOL; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; LYMPHOCYTES; MICROSCOPY, FLUORESCENCE; PROTEIN FOLDING; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS;

EID: 43149098064     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860801927721     Document Type: Article

References (28)

1. Alava, MA, Iturralde, M., Lampreave, F. and Pineiro, A. (1999) Specific uptake of alpha-fetoprotein and albumin by rat Morris 7777 hepatoma cells. Tumour Biol, 20, pp. 52-64.
2. Bennett, JA, Semeniuk, DJ, Jacobson, HI and Murgita, RA (1997) Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth. Breast Cancer Res Treat, 45, pp. 169-179.
3. Bergstrand, GG and Czar, B. (1956) Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest, 8, pp. 174-179.
4. Boismenu, R., DuBow, MS and Murgita, RA (1988) Expression of domains of mouse α-fetoprotein in Escherichia coli. Life Sci, 43, pp. 673-681.
5. Boismenu, R., Semeniuk, D. and Murgita, RA (1997) Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli. Protein Exp Purif, 10, pp. 10-26.
6. Boyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest, 21, pp. 9-18.
7. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, pp. 156-159.
8. Festin, SM, Bennett, JA, Fletcher, PW, Jacobson, HI, Shaye, DD and Andersen, TT (1999) The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule. Biochim Biophys Acta, 24789, pp. 307-314.
9. Gueskens, M., Torres, JM, Esteban, C. and Uriel, J. (1989) Morphological characterization of the pathway of endocytosis and intracellular processing of transferrin and alpha-fetoprotein in human T lymphocytes stimulated with phytohemagglutinin (PHA). Eur J Cell Biol, 50, pp. 418-427.
10. Line, BR, Feustel, PJ, Festin, SM, Andersen, TT, Dansereau, RN, Lukasiewicz, RL, Zhu, S. and Bennett, JA (1999) Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein. Cancer Biother Radiopharm, 14, pp. 485-494.
11. Mizejewski, GJ (2001) Alpha-fetoprotein structure and function: Relevance to isoforms, epitopes, and conformational variants. Exp Biol Med (Maywood), 226, pp. 377-408.
12. Mizejewski, GJ (2003) Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv, 58, pp. 804-826.
13. Mizejewski, GJ, Vonnegut, M. and Jacobson, HI (1983) Estradiol activated α-fetoprotein suppresses the uterotrophic response to estrogens. Proc Natl Acad Sci USA, 80, pp. 2733-2737.
14. Mizejewski, GJ, Dias, JA, Hauer, CR, Henrikson, KP and Gierthy, J. (1996) α-Fetoprotein derived synthetic peptides: Assay of an estrogen-modifying regulatory segment. Mol Cell Endocrinol, 118, pp. 15-23.
15. Morinaga, T., Sakai, M., Wegmann, TG and Tamaoki, T. (1983) Primary structure of human alpha-fetoprotein and mRNA. Proc Natl Acad Sci USA, 80, pp. 4604-4608.
16. Moro, R., Heuguerot, C., Vercelli-Retta, J., Fielitz, W., López, JJ and Roca, R. (1984) The use of radioiodinated AFP for the scintigraphic detection of mouse mammary carcinomas. Nuclear Med Comm, 5, pp. 5-12.
17. Moro, R., Tamaoki, T., Wegmann, TG, Longenecker, BM and Laderoute, MP (1993) Monoclonal antibodies directed against a widespread oncofetal antigen: The alpha-fetoprotein receptor. Tumour Biol, 14, pp. 116-130.
18. Moro, R., Tcherkassova, J. and Song, E. (2005) A new broad-spectrum cancer marker. IVD Technol
19. Moskaleva, EYu, Posypanova, GA, Koromyslova, IA, Shmyrev, II, Krivonos, AV, Myagkikh, IV, Feldman, NB, Finakova, GV, Katukov, VYu, Luzhkov, YuM, Nakachian, R., Andreani, J., Severin, ES and Severin, SE (1996) In vivo antitumor activity of cytotoxic drugs conjugated with human alpha-fetoprotein. Tumor Target, 2, pp. 299-306.
20. Nitsvetov, MB, Rodina, AV, Moskaleva, EYu, Posypanova, GA, Popova, ON, Sologub, VK, Koromyslova, IA, Shmyrev, II, Sotnichenko, AI, Zabolotnev, DV, Karaulov, AV and Severin, SE (2001) Comparison of binding rates of anti-AFPR monoclonal antibodies and AFP during their interactions with human tumor cells. Vopr Biol Med Pharm Chem (Rus), 3, pp. 19-25.
21. Nitsvetov, MB, Moskaleva, EYu, Posypanova, GA, Makarova, OV, Stepanov, VA, Rogov, KA, Koromyslova, IA, Karaulov, AV, Severin, SE and Severin, ES (2005) Immunohistochemical study of AFP receptor expression in normal and malignant tumor human tissues. Immunologiya (Rus), 26, pp. 122-125.
22. Okuda, K., Kotoda, K., Obata, H., Hayashi, N. and Hisamitsu, T. (1975) Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels. Gastroenterology, 69, pp. 226-234.
23. Sambrook, J. and Russell, DW (2001) Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press, New York
24. Severin, SE, Posypanova, GA, Shmyrev, II, Gerasimova, GK, Zhukova, OS, Vorozhtsov, GN, Kaliya, OL, Lukyanets, EA and Severin, ES (1997) Antitumor activity of conjugates of the oncofetal protein alpha-fetoprotein and phthalocyanines in vitro. Biochem Mol Biol Int, 43, pp. 1081-1089.
25. Severin, SE, Posypanova, GA, Sotnichenko, AI, Moskaleva, EYu, Feldman, NB, Grigor'ev, MI, Severin, ES and Petrov, RV (1999) Antitumor activity of a covalent conjugate of the endiene antibiotic esperamicin A1 with human alpha-fetoprotein. Dokl Akad Nauk, 366, pp. 561-564.
26. Uriel, J., Villacampa, MJ, Moro, R., Naval, J. and Failly-Crépin, C. (1984) Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy. Cancer Res, 44, pp. 5314-5319.
27. Villacampa, MJ, Moro, R., Naval, J., Failly-Crepin, C., Lempreave, F. and Uriel, J. (1984) Alpha-fetoprotein receptor in a human breast cancer cell line. Biochem Biophys Res Commun, 122, pp. 1322-1327.
28. Yamamoto, R., Sakamoto, T., Nishi, S., Sakai, M., Morinaga, T. and Tamaoki, T. (1990) Expression of human alpha-fetoprotein in yeast. Life Sci, 46, pp. 1679-1686.